" /> Tafenoquine Succinate - CISMeF





Preferred Label : Tafenoquine Succinate;

NCIt definition : The succinate salt form of tafenoquine, an orally bioavailable 8-aminoquinoline derivative, with antimalarial activity. Although the mechanism is not completely understood, upon administration, tafenoquine inhibits the parasitic enzyme heme polymerase in the blood stages of the parasites. This inhibits the conversion of the toxic heme into non-toxic hemazoin, thereby resulting in the accumulation of toxic heme within the parasite. Tafenoquine is active against all the stages of Plasmodium species and is also active against the pre-erythrocytic liver stages of the parasites. This prevents the development of the erythrocytic forms of the parasite which are responsible for relapses in P. vivax malaria.;

UNII : DL5J0B8VSS;

InChIKey : CQBKFGJRAOXYIP-UHFFFAOYSA-N;

CAS number : 106635-81-8; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 106635-81-8 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : Krintafel; Arakoda;

NCI Metathesaurus CUI : CL553693;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
21/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.